Fortress Biotech
FBIO
$1.80
Share price
3.45%
Change (1 day)
136.84%
Change (1 year)
Categories
P/S ratio for Fortress Biotech (FBIO)
P/S ratio as of May 2024 (TTM): 0.4097
According to Fortress Biotech 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.409666. At the end of 2023 the company had a P/S ratio of 0.5281.
P/S ratio history for Fortress Biotech from 2011 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.5281 | -43.77% |
| 2022 | 0.9393 | -74.06% |
| 2021 | 3.62 | -45.06% |
| 2020 | 6.59 | 26.89% |
| 2019 | 5.19 | |
| 2018 | N/A | -100% |
| 2017 | 1.08 | -86.54% |
| 2016 | 8.01 | -94.75% |
| 2015 | 152 | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Veracyte VCYT | 4.27 | 943.52% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | N/A | N/A | 🇺🇸 USA |
 Advaxis ADXS | 198 | 48,283.56% | 🇺🇸 USA |
 Dynavax Technologies
DVAX | 6.60 | 1,511.74% | 🇺🇸 USA |